BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28297751)

  • 1. VSV-G Viral Envelope Glycoprotein Prepared from
    Liu X; Dong Y; Wang J; Li L; Zhong Z; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
    J Microbiol Biotechnol; 2017 Jun; 27(6):1098-1105. PubMed ID: 28297751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of Viral Glycoprotein VSV-G Improves the Delivery of DNA by Erythrocyte Ghost into Cells Refractory to Conventional Transfection.
    Liu X; Li YP; Zhong ZM; Tan HQ; Lin HP; Chen SJ; Fu YC; Xu WC; Wei CJ
    Appl Biochem Biotechnol; 2017 Feb; 181(2):748-761. PubMed ID: 27665615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors.
    Lo HL; Yee JK
    Curr Protoc Hum Genet; 2007 Jan; Chapter 12():Unit 12.7. PubMed ID: 18428407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer.
    Miyanohara A
    Cold Spring Harb Protoc; 2012 Apr; 2012(4):453-6. PubMed ID: 22474657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
    Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
    J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
    Okimoto T; Friedmann T; Miyanohara A
    Mol Ther; 2001 Sep; 4(3):232-8. PubMed ID: 11545614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
    Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
    Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
    Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors.
    Schneider M; Graham FL; Prevec L
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():417-27. PubMed ID: 2543746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris.
    Wei HY; Jiang LF; Xue YH; Fang DY; Guo HY
    J Virol Methods; 2003 Apr; 109(1):17-23. PubMed ID: 12668263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of N-terminal insertion into VSV-G of an scFv peptide.
    Dreja H; Piechaczyk M
    Virol J; 2006 Sep; 3():69. PubMed ID: 16948856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
    Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
    Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors.
    Hwang BY; Schaffer DV
    Gene Ther; 2013 Aug; 20(8):807-15. PubMed ID: 23364315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.
    Kaikkonen MU; Räty JK; Airenne KJ; Wirth T; Heikura T; Ylä-Herttuala S
    Gene Ther; 2006 Feb; 13(4):304-12. PubMed ID: 16267571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
    Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
    Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.